Study finds distinct oral cancer subtype in patients without traditional risk factors

A June 2026 study in the International Journal of Oral Science identifies a molecular subtype of oral squamous cell carcinoma that appears in people without smoking, alcohol or HPV exposure. Researchers say the tumors are shaped by internal DNA damage and may involve microbial influences, which could change diagnosis and treatment.

Why it matters: - Oral squamous cell carcinoma cases are increasingly appearing in people without the usual risk factors of tobacco, alcohol or oncogenic HPV exposure. - The study says those tumors may form a distinct biological subgroup, which could improve how oral cancers are classified and treated. - The findings point to possible future precision-medicine strategies, including therapies that target DNA damage response pathways or immune evasion.

What happened: - Researchers analyzed tumor mutation patterns to study oral cancers with no identified risk factor, or NIRF OCSCC. - The work was led by Dr. Jiri Zavadil of the International Agency for Research on Cancer and Prof. François Virard of the Cancer Research Center of Lyon. - The study was published in the International Journal of Oral Science on April 24, 2026. - The paper is titled “Mutational signature-based classification uncovers emerging oral cancer subtypes with distinct molecular patterns.” - The DOI is available in the journal record: Full study.

The details: - The team used public cancer data from The Cancer Genome Atlas. - After quality filtering, the analysis included 347 head and neck cancer samples. - The dataset included 253 oral cavity cancers and 94 laryngeal cancers used as smoking-related controls. - The researchers used genomic and multi-omics methods to examine DNA mutations, gene expression and epigenetic changes. - Mutational signatures were used to group tumors by the biological processes driving DNA damage. - The analysis identified four distinct mutational clusters. - Two clusters were strongly linked to known exposures such as smoking and alcohol use, including SBS4 and SBS16. - Laryngeal cancers showed a higher tobacco-related mutation burden than oral cancers, suggesting tissue-specific responses to carcinogens. - Two clusters were enriched for NIRF cases and were dominated by endogenous processes. - Those NIRF clusters were marked mainly by the aging-related SBS1 signature and APOBEC-associated signatures SBS2 and SBS13. - No mutational signatures tied to known environmental carcinogens were found in the NIRF clusters. - The NIRF tumors still showed biological heterogeneity, with one subgroup driven mainly by age-related mutations and another by APOBEC-mediated mutagenesis. - The tumors also carried distinct driver gene mutations linked to immune function and cell signaling. - Gene expression analysis showed activation of antimicrobial and keratinization pathways. - Histopathology found bacterial components in the tumors, pointing to a possible role for the oral microbiome. - The study found immune-evasion features, including changes in antigen presentation pathways. - APOBEC-driven mutagenesis may indicate sensitivity to drugs that target DNA damage response pathways.

Between the lines: - The findings suggest that not all oral cancers follow the same causal path, even when they look similar under the microscope. - The mix of immune changes and bacterial signals raises the possibility that microbes may help shape some tumors, though the study does not prove causation. - The results also show that traditional exposures can affect different head and neck sites differently, with the larynx appearing more mutation-prone than the oral cavity in this dataset. - Dr. Zavadil said the team wanted to determine whether these cancers represent a distinct subtype with unique biological characteristics. - Prof. Virard said the NIRF clusters appeared to be driven by internal processes rather than external exposures.

What’s next: - The study calls for further research into the causes of oral cancers that lack known risk factors. - Future work may test whether microbial involvement contributes to tumor development. - The findings could help refine diagnostic classification for oral squamous cell carcinoma. - The molecular patterns identified here may support more targeted treatment strategies in future trials.

The bottom line: - Oral cancers without traditional risk factors appear to be a distinct molecular entity, not just a variation of the standard disease.